Bovine colostrum in the management of nonorganic failure to thrive: a randomized clinical trial

Yunes Panahi1, Gholamhossein Falahi, Morteza Falahpour

  • 1Research Center of Chemical Injuries, Baqiyatallah Medical Sciences University, Tehran, Iran. yunespanahi@yahoo.com

Insights

Oral bovine colostrum supplementation effectively improved weight gain in children with nonorganic failure to thrive (FTT). This 3-month intervention showed significant positive outcomes without reported side effects, offering a valuable addition to standard FTT management.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Clinical Research

Background:

  • Nonorganic failure to thrive (FTT) affects children's growth and development.
  • Effective management strategies for FTT are crucial for pediatric health.
  • Oral bovine colostrum is explored as a potential therapeutic agent.

Purpose of the Study:

  • To assess the clinical efficacy of oral bovine colostrum in managing nonorganic FTT in children.
  • To determine if bovine colostrum supplementation improves anthropometric indices in FTT patients.
  • To evaluate the safety and effectiveness of bovine colostrum as an adjunct therapy.

Main Methods:

  • A randomized clinical trial involving 120 children (1-10 years) with mild to moderate nonorganic FTT.
  • Participants were assigned to a control group (routine care) or a case group (routine care plus bovine colostrum 40 mg/kg/day for 3 months).
  • Growth was assessed using Gomez (weight for age) and Waterlow I (height for age) indices.

Main Results:

  • The bovine colostrum group showed a significantly higher mean Gomez index (81.72 vs 77.12, P=0.003) after 3 months.
  • A significantly greater proportion of children in the colostrum group achieved healthy status based on the Gomez index (20% vs 3.3%, P=0.006).
  • No significant difference was observed in the Waterlow I index between groups (P=0.094).

Conclusions:

  • Oral bovine colostrum supplementation is a safe and effective adjunct therapy for increasing weight in children with nonorganic FTT.
  • The 3-month supplementation period demonstrated significant improvements in weight gain.
  • Bovine colostrum offers a beneficial, side-effect-free option to enhance standard FTT treatments.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: